SEC Form 4 · accession 0000911916-16-000396
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luc Marengere
Director · 10% Owner
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.50 | Jan 4, 2016 | A | 1,449 | A | Jan 4, 2016 | Jan 4, 2026 | Common Stock | 1,449 | 1,449 | D |
Explanation of responses
- F1This option was issued to the reporting person pursuant to the CoLucid Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash compensation of $10,000.